Juniper Pharmaceuticals' Pending Acquisition

Juniper Pharmaceuticals raised a round of funding on July 05, 2018. Investors include Catalent.

Juniper Pharmaceuticals women's health therapeutic company, focuses on developing therapeutics that address unmet medical needs in women's health. The company develops its products using its drug deli…

Articles about Juniper Pharmaceuticals' Pending Acquisition: